From Banks to FinTech: The Evolution of Small Business Lending — The Consumer Finance Podcast
From Banks to FinTech: The Evolution of Small Business Lending — Payments Pros – The Payments Law Podcast
State AG Pulse | A FAIR Go For NY Consumers
NYS Gov. Hochul’s 2025 State of the State – Legislative Recap
Florida’s Equine Landscape
Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake – Diagnosing Health Care
AI Law in the Commonwealth of Virginia - Recent Developments
Proof in Trial: Moore v. Harper
Video: Things to Remember in Q1 when Preparing 2024 Federal Lobbying Disclosure Act (LDA) Reports
Podcast: Discussing Florida’s 2024 Legislative Session
33rd Annual Legislative Seminar - Senator Shelley Moore Capito, R-W.Va.
33rd Annual Legislative Seminar - Congressman Raja Krishnamoorthi, D-Ill
Orrick Public Policy Podcast #23 – A Conversation with Virginia Delegate Schuyler VanValkenburg
Overview of 87th Texas Legislature
Labor & Employment Law: Vermont and Federal Legislative Update
Lowndes Client Corner Podcast Episode 5 - Winter Park Distilling Company Brews One-Of-A-Kind Facility in Winter Park
Prescription Drug Affordability Boards (PDABs) are becoming a larger part of the state drug price regulatory landscape. The boards are regulatory bodies that review the affordability and cost of specific prescription drugs. ...more
States remain at the forefront of legislative efforts on a range of issues relating to drug pricing, such as increasing price transparency, capping out-of-pocket costs for insulin, and limiting certain PBM practices. These...more
Lawsuit advertisements—specifically ones that target prescription drugs and medical devices—can be dangerous. Nationwide, dramatized and exaggerated legal ads have flooded both televisions and the internet, often masquerading...more
Similar to the laws of several other states, the North Dakota law contains three main disclosure requirements that apply to “drug manufacturers” - The Governor of North Dakota signed House Bill 1032 into law on April 27,...more